SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2878)6/2/2010 1:40:53 PM
From: Jibacoa1 Recommendation  Respond to of 3722
 
ISIS is up 10.36% as it trades at the H for the day.<g>

bigcharts.marketwatch.com

It is holding its annual meeting of stockholders,which is starting about this time.<g>

They will be also holding a scientific presentation starting around 3:00pm and a live audio webcast of it will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.
A replay will be available on the Isis Web site within 48 hours.

ISIS has reported larger losses in the last 4Qs.
The EL for 3010 & 2011 are around #$0.60 & $0.45 vs, $0.28 in 2009

Last month ISIS reported another positive PIII for mipomersen and continued partnering successes with GSK.<g>

They said that in spite of their losses, over the last 3 Yrs, they have strengthened their balance sheet,which is over $650M in cash.

In the 1stQ they reported $880,000 in a non-cash loss related to the impairment of their investment in Antisense Therapeutics.

ISIS nearest resistance is at the $10 level. (It has traded today at $10.04) <g>
Then it has a good amount of resistance from the $11.25 to the $12 level before it can test the Nov11 H at $13.83 <g>

bigcharts.marketwatch.com

The ACTAY is $16.75
But ISIS has a good amount of resistance at the $15 level.<g>

bigcharts.marketwatch.com

Bernard